<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; TSON</title>
	<atom:link href="http://www.stockbloghub.com/tag/tson/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Thu, 24 May 2012 23:16:35 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(BBY) Company News for March 25,2011 &#8211; Corporate Summary</title>
		<link>http://www.stockbloghub.com/2011/03/28/bby-company-news-for-march-252011-corporate-summary-2/69834</link>
		<comments>http://www.stockbloghub.com/2011/03/28/bby-company-news-for-march-252011-corporate-summary-2/69834#comments</comments>
		<pubDate>Mon, 28 Mar 2011 14:01:45 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Electronics Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[BBY]]></category>
		<category><![CDATA[Best Buy Company Inc]]></category>
		<category><![CDATA[C]]></category>
		<category><![CDATA[Citigroup Inc.]]></category>
		<category><![CDATA[Drugstore.com Inc]]></category>
		<category><![CDATA[DSCM]]></category>
		<category><![CDATA[McDermott International Inc.]]></category>
		<category><![CDATA[MDR]]></category>
		<category><![CDATA[MediciNova Inc]]></category>
		<category><![CDATA[MNOV]]></category>
		<category><![CDATA[SFSF]]></category>
		<category><![CDATA[Successfactors Inc]]></category>
		<category><![CDATA[Taleo Corporation]]></category>
		<category><![CDATA[TLEO]]></category>
		<category><![CDATA[TranS1 Inc]]></category>
		<category><![CDATA[TSON]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=69834</guid>
		<description><![CDATA[• Beat Buy (NYSE:BBY) reported Q4 EPS today of $1.98, beating the Zacks Consensus Estimate of $1.84 per share. Revenue for the quarter was down 1.8% year-over-year to $16.3 billion higher than the Zacks Consensus Estimate of $16.298 billion • Walgreen Co. (NYSE:WAG) reported its plan to purchase online pharmacy drugstore.com inc (NASDAQ:DSCM) for $3.80 a share, or about $409 million • Medical-device manufacturer TranS1 Inc (NASDAQ:TSON) said U.S. regulators had cleared its spinal implant system • On late Wednesday, MediciNova Inc&#8217;s (NASDAQ:MNOV) announced an $8.25 million public offering of stock and warrants • Madison Williams analysts initiated coverage on Kinder Morgan (NYSE:KMI) setting a target price of $34.00 with “accumulate” rating • Howard Weil analysts initiated coverage on McDermott International (NYSE:MDR) with an “Outperform” rating with a target price of $30.00 • Oppenheimer initiated coverage on ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/03/28/bby-company-news-for-march-252011-corporate-summary-2/69834/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(BBY) Company News for March 25,2011 &#8211; Corporate Summary</title>
		<link>http://www.stockbloghub.com/2011/03/25/bby-company-news-for-march-252011-corporate-summary/69786</link>
		<comments>http://www.stockbloghub.com/2011/03/25/bby-company-news-for-march-252011-corporate-summary/69786#comments</comments>
		<pubDate>Fri, 25 Mar 2011 19:34:23 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Electronics Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[BBY]]></category>
		<category><![CDATA[Best Buy Company Inc]]></category>
		<category><![CDATA[C]]></category>
		<category><![CDATA[Citigroup Inc.]]></category>
		<category><![CDATA[Drugstore.com Inc]]></category>
		<category><![CDATA[DSCM]]></category>
		<category><![CDATA[McDermott International Inc.]]></category>
		<category><![CDATA[MDR]]></category>
		<category><![CDATA[MediciNova Inc]]></category>
		<category><![CDATA[MNOV]]></category>
		<category><![CDATA[SFSF]]></category>
		<category><![CDATA[Successfactors Inc]]></category>
		<category><![CDATA[Taleo Corporation]]></category>
		<category><![CDATA[TLEO]]></category>
		<category><![CDATA[TranS1 Inc]]></category>
		<category><![CDATA[TSON]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=69786</guid>
		<description><![CDATA[• Beat Buy (NYSE:BBY) reported Q4 EPS today of $1.98, beating the Zacks Consensus Estimate of $1.84 per share. Revenue for the quarter was down 1.8% year-over-year to $16.3 billion higher than the Zacks Consensus Estimate of $16.298 billion • Walgreen Co. (NYSE:WAG) reported its plan to purchase online pharmacy drugstore.com inc (NASDAQ:DSCM) for $3.80 a share, or about $409 million • Medical-device manufacturer TranS1 Inc (NASDAQ:TSON) said U.S. regulators had cleared its spinal implant system • On late Wednesday, MediciNova Inc&#8217;s (NASDAQ:MNOV) announced an $8.25 million public offering of stock and warrants • Madison Williams analysts initiated coverage on Kinder Morgan (NYSE:KMI) setting a target price of $34.00 with “accumulate” rating • Howard Weil analysts initiated coverage on McDermott International (NYSE:MDR) with an “Outperform” rating with a target price of $30.00 • Oppenheimer initiated coverage on ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/03/25/bby-company-news-for-march-252011-corporate-summary/69786/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(TSON) TranS1 Reports Preliminary Revenues</title>
		<link>http://www.stockbloghub.com/2010/01/08/tson-trans1-reports-preliminary-revenues/24515</link>
		<comments>http://www.stockbloghub.com/2010/01/08/tson-trans1-reports-preliminary-revenues/24515#comments</comments>
		<pubDate>Fri, 08 Jan 2010 20:05:02 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[TranS1 Inc]]></category>
		<category><![CDATA[TSON]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=24515</guid>
		<description><![CDATA[TranS1 Inc. (TSON) has reported preliminary revenues for the fourth quarter of 2009. Revenues are expected to be approximately in the range of $6.2 million to $6.3 million, lower than the company’s previous guidance of $6.7 million to $7.2 million. The company expects to report its full fourth quarter results in late February 2010. TranS1 has lowered its guidance on revenues due to concerns in the market regarding reimbursement for its AxiaLIF procedure. The company is addressing these issues through continuous education and support resources for its current and prospective surgeon users. TranS1 is also negotiating with the Centre for Medicare and Medicaid (CMS) and different private payors to settle these issues. TranS1 is a medical device company focused on designing, developing and marketing products that use its proprietary minimally ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/01/08/tson-trans1-reports-preliminary-revenues/24515/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(TSON) TranS1 Trims Third Quarter Outlook</title>
		<link>http://www.stockbloghub.com/2009/10/16/tson-trans1-trims-third-quarter-outlook/17729</link>
		<comments>http://www.stockbloghub.com/2009/10/16/tson-trans1-trims-third-quarter-outlook/17729#comments</comments>
		<pubDate>Sat, 17 Oct 2009 00:21:37 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[TranS1 Inc]]></category>
		<category><![CDATA[TSON]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=17729</guid>
		<description><![CDATA[TranS1 Inc. (TSON) has announced that it expects revenues to be approximately $6.8 million to $6.9 million in the third quarter of 2009 compared to $6 million reported in the year-ago quarter. Results for the quarter are expected to be released on Oct 29, 2009. While revenues are expected to increase from the year-ago period, they are still predicted to be lower than the previous guidance of $7.4 million to $7.9 million. The lower guidance is primarily based on weak sales of the company’s AxiaLIF lumbar fusion device due to insurance reimbursement concerns. However, management considers these low revenues as a short-term event and is confident about long-term growth primarily due to the expanding minimally invasive spine surgery market. TranS1 is working on educating existing and potential customers about the ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/10/16/tson-trans1-trims-third-quarter-outlook/17729/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

